Kentucky Retirement Systems’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.93M Sell
78,623
-47,973
-38% -$6.32M 0.25% 71
2026
Q1
$9.51M Buy
126,596
+48,403
+62% +$6.78M 0.7% 32
2025
Q4
$9.6M Hold
78,193
0.26% 74
2025
Q3
$8.68M Sell
78,193
-1,804
-2% -$205K 0.24% 82
2025
Q2
$8.87M Sell
79,997
-5,243
-6% -$558K 0.26% 75
2025
Q1
$9.55M Sell
85,240
-314
-0.4% -$32.4K 0.29% 65
2024
Q4
$7.9M Sell
85,554
-1,179
-1% -$106K 0.23% 81
2024
Q3
$7.27M Sell
86,733
-7,150
-8% -$546K 0.21% 95
2024
Q2
$6.44M Sell
93,883
-742
-0.8% -$49.5K 0.19% 107
2024
Q1
$6.93M Sell
94,625
-5,072
-5% -$390K 0.21% 103
2023
Q4
$8.08M Buy
99,697
+3,008
+3% +$234K 0.25% 86
2023
Q3
$7.25M Sell
96,689
-3,601
-4% -$277K 0.25% 83
2023
Q2
$7.73M Buy
100,290
+1,693
+2% +$135K 0.26% 84
2023
Q1
$8.18M Buy
98,597
+55
+0.1% +$4.55K 0.3% 75
2022
Q4
$8.46M Buy
98,542
+431
+0.4% +$34.1K 0.33% 71
2022
Q3
$6.05M Buy
98,111
+5,017
+5% +$316K 0.26% 81
2022
Q2
$5.75M Buy
93,094
+13,139
+16% +$813K 0.24% 89
2022
Q1
$4.75M Buy
79,955
+4,823
+6% +$308K 0.19% 107
2021
Q4
$5.46M Buy
75,132
+2,318
+3% +$160K 0.22% 94
2021
Q3
$5.09M Sell
72,814
-218
-0.3% -$15.3K 0.24% 91
2021
Q2
$5.03M Buy
73,032
+233
+0.3% +$15.6K 0.24% 93
2021
Q1
$4.71M Sell
72,799
-7,583
-9% -$489K 0.23% 97
2020
Q4
$4.68M Buy
80,382
+7,301
+10% +$441K 0.24% 95
2020
Q3
$4.62M Buy
73,081
+3,269
+5% +$227K 0.28% 76
2020
Q2
$5.37M Sell
69,812
-16,592
-19% -$1.27M 0.38% 60
2020
Q1
$6.46M Buy
86,404
+21,318
+33% +$1.47M 0.44% 53
2019
Q4
$4.23M Buy
65,086
+191
+0.3% +$12.4K 0.31% 72
2019
Q3
$4.11M Buy
64,895
+5,679
+10% +$371K 0.33% 70
2019
Q2
$4M Buy
59,216
+3,450
+6% +$227K 0.35% 65
2019
Q1
$3.63M Sell
55,766
-504
-0.9% -$33.5K 0.35% 65
2018
Q4
$3.52M Buy
56,270
+1,066
+2% +$74.5K 0.39% 62
2018
Q3
$4.26M Sell
55,204
-2
-0% -$151 0.41% 59
2018
Q2
$3.91M Sell
55,206
-13,159
-19% -$929K 0.4% 58
2018
Q1
$5.15M Sell
68,365
-12,189
-15% -$969K 0.44% 52
2017
Q4
$5.77M Buy
80,554
+319
+0.4% +$24.2K 0.41% 54
2017
Q3
$6.5M Sell
80,235
-3,532
-4% -$270K 0.49% 46
2017
Q2
$5.93M Sell
83,767
-33
-0% -$2.2K 0.45% 45
2017
Q1
$5.69M Sell
83,800
-11,801
-12% -$830K 0.44% 46
2016
Q4
$6.85M Sell
95,601
-5,258
-5% -$391K 0.49% 44
2016
Q3
$7.98M Sell
100,859
-12,396
-11% -$1.01M 0.53% 41
2016
Q2
$9.45M Sell
113,255
-12,319
-10% -$1.09M 0.61% 38
2016
Q1
$11.5M Buy
125,574
+16,110
+15% +$1.45M 0.7% 31
2015
Q4
$11.1M Buy
109,464
+8,762
+9% +$912K 0.82% 26
2015
Q3
$9.89M Buy
100,702
+1,542
+2% +$171K 0.85% 22
2015
Q2
$11.6M Sell
99,160
-1,088
-1% -$119K 0.94% 18
2015
Q1
$9.84M Sell
100,248
-11,900
-11% -$1.21M 0.8% 24
2014
Q4
$10.6M Sell
112,148
-5,455
-5% -$564K 0.78% 26
2014
Q3
$12.5M Buy
+117,603
New +$11.5M 0.92% 20
2014
Q1
$9.04M Buy
127,509
+913
+0.7% +$71.6K 0.65% 33
2013
Q4
$9.51M Sell
126,596
-542
-0.4% -$37.7K 0.7% 32
2013
Q3
$7.99M Buy
+127,138
New +$7.6M 0.64% 33

Other funds holding GILD

Kentucky Retirement Systems's GILD Position: Q2 2026 in Review

Kentucky Retirement Systems reduced its Gilead Sciences (GILD) stake by 38% in Q2 2026, selling an estimated $6.32M and leaving 78,623 shares worth $9.93M. The position accounts for 0.25% of the portfolio, ranked #71.

Kentucky Retirement Systems first reported a position in GILD in Q3 2013 and has held it in 51 quarters since. The position peaked at $12.5M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kentucky Retirement Systems held 78,623 shares of Gilead Sciences worth $9.93M as of Q2 2026.
  • Kentucky Retirement Systems sold 47,973 Gilead Sciences shares in Q2 2026, an estimated $6.32M.
  • Gilead Sciences made up 0.25% of Kentucky Retirement Systems's portfolio in Q2 2026, its #71 holding.
  • Kentucky Retirement Systems first reported a position in Gilead Sciences in Q3 2013 and has held it in 51 quarters since.
  • Kentucky Retirement Systems's Gilead Sciences position peaked at $12.5M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kentucky Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.